Cargando…
LncRNA-H19 regulates chemoresistance to carboplatin in epithelial ovarian cancer through microRNA-29b-3p and STAT3
Background: Platinum-based chemotherapy is part of current standard treatment for epithelial ovarian cancer (EOC). However, chemoresistance often rapidly developed, leading to chemotherapy failure and unfavored prognosis. Increasing evidence has demonstrated the important role of oncogenic long nonc...
Autores principales: | Tian, Xueye, Zuo, Xiaohang, Hou, Meng, Li, Chen, Teng, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408112/ https://www.ncbi.nlm.nih.gov/pubmed/34475985 http://dx.doi.org/10.7150/jca.58979 |
Ejemplares similares
-
Long Non-Coding RNA (lncRNA) BMP/OP-Responsive Gene (BORG) Promotes Development of Chemoresistance of Colorectal Cancer Cells to Carboplatin
por: Li, Junliang, et al.
Publicado: (2020) -
PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance
por: Tabury, Kevin, et al.
Publicado: (2022) -
Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2023) -
Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
por: Qin, Shuang, et al.
Publicado: (2023) -
lncRNA/MicroRNA interactions in the vasculature
por: Ballantyne, MD, et al.
Publicado: (2016)